I-Corps for Fischer Imaging's MammoCAT novel slot scanning mammography

项目摘要 Fischer Imaging开发了MammoCAT，这是一种使用我们的 专有的槽扫描技术（SST）。SST消除了来自 测量，从而使用少于一半的剂量使图像分辨率和对比度加倍。 标准的乳房X光检查MammoCAT可应用于标准平面数字乳腺X射线摄影 (DM)以及更新的乳房X线摄影技术，例如数字乳房断层合成（DBT）和 乳腺计算机断层扫描（BCT）。该提案旨在招募NIH/NCI I-Corps 计划，以帮助确定我们的介绍产品，通过了解临床医生 每个系统的偏好、定价和报销的影响， 产品发布战略。 乳房X线摄影仍然是乳腺癌筛查的重要诊断工具， 诊断并帮助挽救了数千人的生命。不幸的是，不是每个女人 常规筛查被乳房X光检查所拯救， 由于假阳性而进行不必要的测试、活检和治疗。我们的创新 一种无散射的高速、高分辨率检测方法将有助于MammoCAT提高 乳腺X线摄影的灵敏度和特异性，同时也提高了乳腺X线摄影的效率， 癌症检测和诊断，消除了额外或替代测试的需要， 可以进行治疗。我们相信MammoCAT CT将开创一个新时代， 女性将受益于乳房X光检查，在那里肿瘤可以被检测，诊断和 在同一设备中进行活检，从而改善设备和空间利用率， 工作流

PROJECT SUMMARY Fischer Imaging has developed MammoCAT, a device for improved mammography using our proprietary Slot Scanning Technology (SST). SST eliminates scattered radiation from the measurement thereby doubling image resolution and contrast using less than half the dose of standard mammography. MammoCAT can be applied to standard planar digital mammography (DM) and to newer mammography techniques such as digital breast tomosynthesis (DBT) and breast computed tomography (BCT). This proposal seeks enrollment in the NIH/NCI I-Corps program to help determine our introductory product through an understanding of clinician preferences for each system, the impact of pricing and reimbursement and help craft our product launch strategy. Mammography continues to be an important diagnostic tool for breast cancer screening and diagnosis and has helped save thousands of lives. Unfortunately, not every woman who gets routine screening is saved by mammography and an unacceptably large number of women are subjected unnecessary testing, biopsy and treatment due to false positives. Our innovative approach to scatter free high speed, high resolution detection will help MammoCAT improve the sensitivity and specificity of mammography whilst also improving the efficiencies of breast cancer detection and diagnosis by removing the need for additional or alternative testing before therapy can be rendered. We believe MammoCAT CT will usher in a new era where every woman will benefit from mammography and where tumors can be detected, diagnosed and biopsied in the same device thus improving equipment and space utilization and hospital workflow.